Real-Life Effectiveness and Tolerability of Brivaracetam in Focal to Bilateral and Primary Generalized Tonic-Clonic Seizures

Figure 1

Brivaracetam dose and seizure frequency at follow-up. The figure shows increasing doses in the first 3 to 6 months of treatment, with stabilization at 6-12 months. Median seizure frequency (both FBTCS/GTCS and overall seizures) is seen to decrease since the baseline visit. FBTCS/GTCS remain near 0 after 3 months of treatment. BRV: brivaracetam; FBTCS/GTCS: focal to bilateral tonic-clonic seizures/generalized tonic-clonic seizures.